Medical Science Liaison - Cell Therapy - Czech Republic at Gilead Sciences

Prague, Prague, Czechia

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biopharmaceutical, Biotechnology, OncologyIndustries

Requirements

Knowledgeable and motivated professional capable of working effectively in a cross-functional team environment
Field-based position requiring 80-90% travel to hemato-oncology centers in Czech Republic
Reports to Country Medical Lead Cell Therapy CZ & SK
Support and back-up/deputy of Country Medical Lead for specific areas (e.g., certification of hematology-oncology centers, support of certified centers, Risk Management Plan)

Responsibilities

Identify and develop regional and national opinion leaders to support cell therapy products through personal contacts and on-site visits
Establish strong relationships with opinion leaders and clinical investigators at academic and non-academic settings
Collaborate cross-functionally with commercial CTAMs (Cell Therapy Account Managers), Case Manager, BUD
Serve as external scientific expert in the therapy area, healthcare landscape, and data on Kite and competitor therapies
Partner with colleagues and serve as the external medical affairs representative in the cross-functional therapeutic team
Identify and establish strategic relationships with key external stakeholders at a national level
Collaborate with the cross-functional team to develop and manage national thought leader engagement plans
Serve as company ambassador to professional societies, academic & research centres, patient & advocacy groups, and at national & international scientific meetings
Develop and present complex scientific and clinical data on Kite medicines and related therapy areas
Coordinate and answer complex responses to clinical inquiries from healthcare professionals
Obtain external insights and support the development of medical strategies

Skills

Medical Science Liaison

Cell Therapy

CAR-T

TCR

Cancer Immunotherapy

Chimeric Antigen Receptor

T Cell Receptor

KOL Engagement

Scientific Communication

Oncology

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free